The present invention discloses compounds of Formula I: wherein the variables in Formula I are defined as described herein. Also disclosed are pharmaceutical compositions containing such compounds and methods for using the compounds of Formula I in the prevention or treatment of HCV infection.
申请公布号
WO2014006066(A1)
申请公布日期
2014.01.09
申请号
WO2013EP63980
申请日期
2013.07.03
申请人
F. HOFFMANN-LA ROCHE AG;HOFFMANN-LA ROCHE INC.
发明人
BILOTTA, JOSEPH ANTHONY;CHEN, ZHI;CHIN, ELBERT;DING, QINGJIE;ERICKSON, SHAWN DAVID;GABRIEL, STEPHEN DEEMS;KLUMPP, KLAUS;MA, HAN;MERTZ, ERIC;PLANCHER, JEAN-MARC;WEIKERT, ROBERT JAMES